BIRNDORF HOWARD C 4
4 · Adamis Pharmaceuticals Corp · Filed Nov 16, 2022
Insider Transaction Report
Form 4
BIRNDORF HOWARD C
Director
Transactions
- Disposition to Issuer
Warrant to Purchase Common Stock
2022-11-14−58,824→ 0 totalExercise: $8.50Exp: 2022-11-15→ Common Stock (58,824 underlying) - Award
Warrant to Purchase Common Stock
2022-11-14+58,824→ 58,824 totalExercise: $8.50Exp: 2023-11-15→ Common Stock (58,824 underlying)
Footnotes (1)
- [F1]The two reported transactions involved an amendment to extend the term of an outstanding investor warrant originally issued on November 15, 2007.